US breast cancer mortality has more than halved since 1975, but the decline has not been shared equally. Black women’s death rates remain 36% higher than White women’s, and rates among American Indian and Alaska Native women have not fallen in three decades. Within-subtype survival gaps are widest in hormone recept...
Abhinav Vayal-Veettil, J. Hundal, Jame Abraham· Frontiers in Oncology· 0 citations
238
Background:
Pembrolizumab plus chemotherapy is standard neoadjuvant therapy for high-risk early-stage triple-negative breast cancer (TNBC) per KEYNOTE-522. Prior real-world studies have documented Black-White disparities in initial KEYNOTE-522 receipt and regimen tolerability, but the discrete neoadjuvant-t...
Abhinav Vayal-Veettil, J. Hundal, Jame Abraham· JCO Oncology Practice· 0 citations
276
Background:
Patients receiving immunotherapy frequently experience cancer-related fatigue, symptom burden, and impaired health-related quality of life (HRQOL). Although exercise can improve patient-reported outcomes, the mechanisms underlying its effects remain unclear; this study evaluated whether reductio...
P. G. Bergerot, C. Bergerot, P. W. Schorn et al.· JCO Oncology Practice· 0 citations
It is observed that South Asian American women were diagnosed at younger ages, more frequently presented with aggressive forms of the disease, and experienced longer delays before starting treatment, although delays before surgery were associated with higher mortality.
J. Hundal, Ishan Gupta, Ashiya Loomba et al.· Cancers· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.